High-Resolution Genomic Profiling of Carboplatin Resistance in Early-Stage Epithelial Ovarian Carcinoma

Publisher： Karger

E-ISSN： 1424-859x|125|1|8-18

ISSN： 1424-8581

Source： Cytogenetic and Genome Research, Vol.125, Iss.1, 2009-07, pp. : 8-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison Of Early-Stage High-Grade Serous Primary Fallopian Tube Cancers and Epithelial Ovarian Cancers: A Multicenter Study

By  

Oncology Research and Treatment, Vol. 40, Iss. 4, 2017-03 ,pp. : 203-206

Karger

Access to resources Recommend Favorite

A Risk-Adapted Strategy of Adjuvant Paclitaxel/Carboplatin in Early-Stage Ovarian Cancer: Time-Dependent Effect of 4 versus 6 Cycles on Outcome

By  

Oncology, Vol. 81, Iss. 5-6, 2012-01 ,pp. : 365-371

Karger

Access to resources Recommend Favorite

A 2‐stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early‐stage incident cancers and demonstrates high positive predictive value

By  

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3454-3461

John Wiley & Sons Inc

Access to resources Recommend Favorite

ALCHEMIST: Bringing genomic discovery and targeted therapies to early‐stage lung cancer

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 5, 2015-05 ,pp. : 447-450

John Wiley & Sons Inc

Access to resources Recommend Favorite

Paclitaxel plus Carboplatin Chemotherapy for Primary Peritoneal Carcinoma: A Study of 22 Cases and Comparison with Stage III–IV Ovarian Serous Carcinoma

By  

Case Reports in Oncology, Vol. 5, Iss. 1, 2012-04 ,pp. : 173-180

Karger

Access to resources Recommend Favorite